Great News For Our Young Kids
Pfizer made an announcement Monday saying that a Phase 2/3 trial showed its Covid-19 vaccine was safe and generated a “robust” antibody response in children ages 5-11.
This is the first time such results have been released for this age group. Pfizer plans to submit its plan to the U.S. Food and Drug Administration (FDA) for emergency use soon.
The trial included 2,268 people ages 5 to 11 years old. This trial used 10-microgram doses, smaller than the 30-microgram doses used on older than 16 year olds. It demonstrated a strong immune response.
Since July of this year, pediatric cases of Covid-19 have risen 240 percent in the U.S. Pfizer plans to have a vaccine for children ages 5-11 available by Halloween.
U.S. health officials have emphasized that children are not just small adults and even those approaching age 12 should not be given the larger vaccine doses available for older people.
This is really great news for all of us. Over the past several months, many kids have contracted Covid-19 and made life very difficult for their families. Now they might feel a little more relaxed. For now, almost 29% of all Covid-19 cases reported in the U.S. are children under 16.
It has been almost two years now since we all have been suffering from the pandemic that has brought us so much pain. We really appreciate all the scientists who do such a great job to come to the rescue of our society.